학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 6건 | 목록 1~10
Academic Journal
Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Tudini E; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Li H; Cancer Control and Population Science, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Hahnen E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Wappenschmidt B; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Feliubadaló L; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Aalfs CM; Department of Clinical Genetics, Amsterdam UMC, Amsterdam, The Netherlands.; Agata S; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy.; Aittomäki K; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.; Alducci E; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy.; Alonso-Cerezo MC; Clinical Genetics, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria, Madrid, Spain.; Arnold N; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.; Institute of Clinical Molecular Biology, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.; Auber B; Institute of Human Genetics, Hannover Medical School, Hannover, Germany.; Austin R; Genetic Health Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia.; Azzollini J; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Balmaña J; High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, University Hospital of Vall d'Hebron, Barcelona, Spain.; Barbieri E; Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.; Bartram CR; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.; Blanco A; Fundación Pública galega Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain.; Blümcke B; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Bonache S; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Bonanni B; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Borg Å; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.; Bortesi B; Division of Oncology, University Hospital of Parma, Parma, Italy.; Brunet J; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Bruzzone C; Unit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Bucksch K; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.; Cagnoli G; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Caldés T; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.; Caliebe A; Institute of Human Genetics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.; Caligo MA; SOD Genetica Molecolare, University Hospital, Pisa, Italy.; Calvello M; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Capone GL; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, University of Florence, Florence, Italy.; Caputo SM; Service de Génétique, Institut Curie, Paris, France.; Paris Sciences Lettres Research University, Paris, France.; Carnevali I; UO Anatomia Patologica, Ospedale di Circolo ASST Settelaghi, Varese, Italy.; Carrasco E; High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Caux-Moncoutier V; Service de Génétique, Institut Curie, Paris, France.; Cavalli P; Servizio di Genetica, ASST di Cremona, Cremona, Italy.; Cini G; Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.; Clarke EM; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Concolino P; Fondazione Policlinico Universitario A.Gemelli, IRCCS, Rome, Italy.; Cops EJ; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Cortesi L; Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.; Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.; Darder E; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; de la Hoya M; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.; Dean M; Laboratory of Translational Genomics, DCEG, National Cancer Institute, Gaithersburg, Maryland.; Debatin I; Institute of Human Genetics, University Hospital Ulm, Ulm, Germany.; Del Valle J; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Delnatte C; Laboratoire de Genetique Moleculaire, CHU Nantes, Nantes, France.; Derive N; Service de Génétique, Institut Curie, Paris, France.; Paris Sciences Lettres Research University, Paris, France.; Diez O; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Clinical and Molecular Genetics Area, University Hospital Vall d'Hebron, Barcelona, Spain.; Ditsch N; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany.; Domchek SM; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.; Dutrannoy V; Institute of Medical and Human Genetics, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Eccles DM; Faculty of Medicine, University of Southampton, Southampton, UK.; Ehrencrona H; Department of Clinical Genetics and Pathology, Laboratory Medicine, Office for Medical Services - Region Skåne, Lund, Sweden.; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.; Enders U; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.; Evans DG; Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary's Hospital, Manchester, UK.; Genomic Medicine, North West Genomics hub, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary's Hospital, Manchester, UK.; Farra C; Medical Genetics, American University of Beirut Medical Center, Beirut, Lebanon.; Faust U; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.; Felbor U; Institute of Human Genetics, University Medicine Greifswald, Greifswald, Germany.; Feroce I; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Fine M; Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, Australia.; Foulkes WD; Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, QC, Canada.; Galvao HCR; Oncogenetics Department, Barretos Cancer Hospital, São Paulo, Brazil.; Gambino G; SOD Genetica Molecolare, University Hospital, Pisa, Italy.; Gehrig A; Department of Human Genetics, University of Würzburg, Würzburg, Germany.; Gensini F; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, University of Florence, Florence, Italy.; Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Germani A; Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University, Rome, Italy.; Giesecke J; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Gismondi V; Unit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Gómez C; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Gómez Garcia EB; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.; González S; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Grau E; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Grill S; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen, Universität München, Munich, Germany.; Gross E; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany.; Guerrieri-Gonzaga A; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Guillaud-Bataille M; Departement de Biopathologie, Gustave Roussy, Universite Paris-Saclay, Villejuif, France.; Gutiérrez-Enríquez S; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Haaf T; Department of Human Genetics, University of Würzburg, Würzburg, Germany.; Hackmann K; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; Hansen TVO; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Harris M; Familial Cancer Centre, Monash Health, Clayton, Australia.; Hauke J; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Heinrich T; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.; Hellebrand H; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen, Universität München, Munich, Germany.; Herold KN; The City of Hope, Duarte, California.; Honisch E; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.; Horvath J; Institute of Human Genetics, University of Münster, Münster, Germany.; Houdayer C; Department of Genetics, F76000 and Normandy University, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, Rouen, France.; Hübbel V; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Iglesias S; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Izquierdo A; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; James PA; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Janssen LAM; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.; Jeschke U; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany.; Kaulfuß S; Institute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.; Keupp K; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Kiechle M; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen, Universität München, Munich, Germany.; Kölbl A; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany.; Krieger S; Laboratoire de Biologie Clinique et Oncologique, Centre Francois Baclesse, Caen, France.; Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.; Normandie Université, UNICAEN, Caen, France.; Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark.; Kvist A; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.; Lalloo F; Genomic Medicine, North West Genomics hub, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary's Hospital, Manchester, UK.; Larsen M; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Lattimore VL; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.; Lautrup C; Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Ledig S; Institute of Human Genetics, University of Münster, Münster, Germany.; Leinert E; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.; Lewis AL; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Lim J; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Loeffler M; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.; López-Fernández A; High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Lucci-Cordisco E; UOC Genetica Medica, Fondazione Policlinico Universitario A.Gemelli IRCCS and Istituto di Medicina Genomica, Università Cattolica del Sacro Cuore, Rome, Italy.; Maass N; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.; Manoukian S; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Marabelli M; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Matricardi L; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy.; Meindl A; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany.; Michelli RD; Oncogenetics Department, Barretos Cancer Hospital, São Paulo, Brazil.; Moghadasi S; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.; Moles-Fernández A; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Montagna M; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy.; Montalban G; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Monteiro AN; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida.; Montes E; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Mori L; Department of Clinical and Experimental Science, University of Brescia c/o 2nd Internal Medicine, Hospital of Brescia, Brescia, Italy.; Moserle L; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy.; Müller CR; Department of Human Genetics, University of Würzburg, Würzburg, Germany.; Mundhenke C; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.; Naldi N; Division of Oncology, University Hospital of Parma, Parma, Italy.; Nathanson KL; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.; Navarro M; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.; Nichols CB; Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Australia.; Niederacher D; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.; Nielsen HR; Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark.; Ong KR; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Birmingham, UK.; Pachter N; Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Australia.; Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia.; Palmero EI; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.; Barretos School of Health Sciences, Dr. Paulo Prata - FACISB, São Paulo, Brazil.; Papi L; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, University of Florence, Florence, Italy.; Pedersen IS; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; Peissel B; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Perez-Segura P; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.; Pfeifer K; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen, Universität München, Munich, Germany.; Pineda M; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Pohl-Rescigno E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Poplawski NK; Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, Australia.; School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, Australia.; Porfirio B; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, University of Florence, Florence, Italy.; Quante AS; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen, Universität München, Munich, Germany.; Ramser J; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen, Universität München, Munich, Germany.; Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.; Health Sciences School, University of Minho, Braga, Portugal.; ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.; Revillion F; Laboratoire d'Oncogenetique Moleculaire Humaine, Centre Oscar Lambret, Lille, France.; Rhiem K; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Riboli B; Servizio di Genetica, ASST di Cremona, Cremona, Italy.; Ritter J; Institute of Medical and Human Genetics, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Rivera D; Unit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Rofes P; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Rump A; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; Salinas M; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Sánchez de Abajo AM; Servicio de Análisis Clínicos y Bioquímica Clínica, Complejo Hospitalario, Universitario Insular Materno-Infantil de Gran Canaria, Las Palmas de Gran Canaría, Spain.; Schmidt G; Institute of Human Genetics, Hannover Medical School, Hannover, Germany.; Schoenwiese U; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.; Seggewiß J; Institute of Human Genetics, University of Münster, Münster, Germany.; Solanes A; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Steinemann D; Institute of Human Genetics, Hannover Medical School, Hannover, Germany.; Stiller M; Institute of Human Genetics, University Hospital Leipzig, Leipzig, Germany.; Stoppa-Lyonnet D; Service de Génétique, Institut Curie, Paris, France.; Department of Tumour Biology, INSERM U830, Paris, France.; Université Paris Descartes, Paris, France.; Sullivan KJ; Genetic Health Service NZ- Northern Hub, Auckland District Health Board, Auckland, New Zealand.; Susman R; Genetic Health Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia.; Sutter C; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.; Tavtigian SV; Department of Oncological Services, University of Utah School of Medicine, Salt Lake City, Utah.; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Teo SH; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Department of Surgery, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.; Teulé A; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark.; Tibiletti MG; UO Anatomia Patologica, Ospedale di Circolo ASST Settelaghi, Varese, Italy.; Tischkowitz M; Department of Medical Genetics, University of Cambridge, Cambridge, UK.; Tognazzo S; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy.; Toland AE; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, Ohio.; Tornero E; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Törngren T; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.; Torres-Esquius S; High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Toss A; Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.; Trainer AH; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Department of medicine, University of Melbourne, Melbourne, Victoria, Australia.; Tucker KM; Prince of Wales Clinical School, University of NSW, Sydney, New South Wales, Australia.; Hereditary Cancer Clinic, Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia.; van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.; van Mackelenbergh MT; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.; Varesco L; Unit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Vargas-Parra G; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Varon R; Institute of Medical and Human Genetics, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Vega A; Fundación Pública galega Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain.; Velasco Á; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; Vesper AS; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.; Viel A; Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.; Vreeswijk MPG; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.; Wagner SA; Department of Medicine, Hematology/Oncology, Goethe-University Frankfurt, Frankfurt, Germany.; Waha A; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Walker LC; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.; Walters RJ; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Wang-Gohrke S; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.; Weber BHF; Institute of Human Genetics, University Regensburg, Regensberg, Germany.; Weichert W; Institute of Pathology, Technische Universität München, Munich, Germany.; Wieland K; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.; Wiesmüller L; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.; Witzel I; Department of Gynecology, University Medical Center Hamburg, Hamburg, Germany.; Wöckel A; Department of Gynecology and Obstetrics, University Hospital Würzburg, Würzburg, Germany.; Woodward ER; Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary's Hospital, Manchester, UK.; Genomic Medicine, North West Genomics hub, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary's Hospital, Manchester, UK.; Zachariae S; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.; Zampiga V; Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.; Zeder-Göß C; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany.; Lázaro C; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.; De Nicolo A; Cancer Genomics Program, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.; Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.; Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.; Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Goldgar DE; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah.; Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9215429 Publication Model: Print Cited Medium: Internet ISSN: 1098-1004 (Electronic) Linking ISSN: 10597794 NLM ISO Abbreviation: Hum Mutat Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Hubbel, Alexandra
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어